cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2004; 44:887-891, doi:10.1016/j.jacc.2004.05.052
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hansen, A.
Right arrow Articles by Kuecherer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hansen, A.
Right arrow Articles by Kuecherer, H.

ECHOCARDIOGRAPHY

Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography

Alexander Hansen, MD{dagger},*, Anjali Kumar, PhD*, David Wolf, BS{dagger}, Kamilla Frankenbergerova, BS{dagger}, Arthur Filusch, MD{dagger}, Marie-Luise Gross, MD{ddagger}, Sebastian Mueller, MD{dagger}, Hugo Katus, MD{dagger} and Helmut Kuecherer, MD{dagger}

* Wyeth Research, Cambridge, Massachusetts, USA
{dagger} Cardiology
{ddagger} Pathology, University of Heidelberg, Heidelberg, Germany

Manuscript received February 9, 2004; revised manuscript received April 22, 2004, accepted May 2, 2004.

* Reprint requests and correspondence: Dr. Alexander Hansen, Department of Cardiology, University of Heidelberg, Bergheimerstr. 58, 69115 Heidelberg, Germany (Email: alexander_hansen{at}med.uni-heidelberg.de).

OBJECTIVES: The purpose was to examine the cardioprotective effects of recombinant P-selectin glycoprotein ligand-immunoglobulin (rPSGL-Ig) in ischemia-reperfusion injury by real-time myocardial contrast echocardiography (MCE).

BACKGROUND: P-selectin mediates leukocyte recruitment into areas of inflammation.

METHODS: Sixteen pigs underwent 45 min of left anterior descending coronary artery occlusion followed by reperfusion and received rPSGL-Ig or vehicle. To assess changes in myocardial perfusion (A x ß), MCE was performed.

RESULTS: After 120 min of reperfusion, A x ß in the risk area was higher (0.84 ± 0.15 dB/s vs. 0.28 ± 0.1 dB/s, p < 0.0001), and the infarct size was lower (30.3 ± 12% vs. 57 ± 14%, p = 0.002) in the rPSGL-Ig group compared with the vehicle group.

CONCLUSIONS: Recombinant PSGL-Ig improved postischemic reflow accurately detected by real-time MCE.

Abbreviations and Acronyms
  A x ß = myocardial perfusion
  FAS = fractional area shortening
  LAD = left anterior descending coronary artery
  LV = left ventricle
  MBF = myocardial blood flow
  MCE = myocardial contrast echocardiography
  PSGL-1 = P-selectin glycoprotein ligand-1
  rPSGL-Ig = recombinant P-selectin glycoprotein ligand-immunoglobulin




This article has been cited by other articles:


Home page
HeartHome page
G Korosoglou, A Hansen, R Bekeredjian, A Filusch, S Hardt, D Wolf, D Schellberg, H A Katus, and H Kuecherer
Usefulness of myocardial parametric imaging to evaluate myocardial viability in experimental and in clinical studies
Heart, March 1, 2006; 92(3): 350 - 356.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. E. Weyman
The year in echocardiography
J. Am. Coll. Cardiol., February 1, 2005; 45(3): 448 - 455.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home